ArticleFrontiers in oncology2024

Conserving surgery in inflammatory breast cancer after neoadjuvant chemotherapy in patients with clinical complete response: the ConSIBreC randomized controlled trial.

Lorenzo Scardina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.